Skip to content
National Drug Intelligence Center National Drug Intelligence Center Seal.
Updated on July 31, 2009

 

The mission of NDIC is to provide strategic drug-related intelligence, document and computer exploitation support, and training assistance

to the drug control, public health, law enforcement, and intelligence communities of the United States

in order to reduce the adverse effects of drug trafficking, drug abuse, and other drug-related criminal activity.

TTY users please call (814) 532-5815.

News

Deputy Director Vacancy Announced

The U.S. Department of Justice has advertised the Deputy Director position at NDIC. This announcement is open to all sources and is available on USAJOBS at: http://jobview.usajobs.gov/GetJob.aspx?JobID=82461943&q=justice&sort=rv%2c-dtex&jbf565=1&vw=d&re=134&FedEmp=N&FedPub=Y&caller=ses.aspx&AVSDM=2009-07-27+07%3a46%3a00&rc=3&TabNum=7

If you have any questions regarding this announcement, please contact Ms. Kimberly Jackson at (202) 514-4350 or e-mail Kimberly.W.Jackson@usdoj.gov.
 

2009 Drug Market Analyses for the High Intensity Drug Trafficking Areas Available

The National Drug Intelligence Center (NDIC) announces the release of 32 High Intensity Drug Trafficking Area (HIDTA) Drug Market Analyses (DMA) for 2009. These reports, produced at the request of the Office of National Drug Control Policy, provide a strategic overview of the illicit drug situation in each of the HIDTA regions.

The 32 DMAs are:

 

Methamphetamine Report added

Situation Report: Pseudoephedrine Smurfing Fuels Surge in Large-Scale Methamphetamine Production in California
This Situation Report is in response to a request from the Office of National Drug Control Policy for information regarding pseudoephedrine smurfing in California. The National Drug Intelligence Center collected and analyzed data and reporting from 2007-through May 2009 related to methamphetamine production and pseudoephedrine smurfing. This report draws upon data from the National Seizure System, as well as information obtained through interviews with federal, state, and local law enforcement officers.

 
Employees of the National Drug Intelligence Center Receive Excellence in Government Awards

June 1, 2009 - In their annual Excellence in Government Awards ceremony, the Pittsburgh Federal Executive Board recognized 22 National Drug Intelligence Center (NDIC) employees for their “deep personal and professional commitment” over the past year.
 

Multiagency Course August training sites changed

The site locations for the August Multiagency Course training have been changed: Johnston, RI, is cancelled, and the Washington, D.C. area class will be held in Herndon, VA. For further information see our Multiagency Course page.
 

NDIC FY08 Accomplishments announced

The National Drug Intelligence Center (NDIC) has consistently and effectively supported national policymakers and law enforcement decisionmakers by providing:

  • high-quality strategic domestic drug intelligence;

  • facilitating information sharing and liaison between intelligence and law enforcement agencies;

  • providing timely operational support to law enforcement authorities by conducting document and media exploitation of evidence collected during federal, state, and local law enforcement investigations;

  • and providing training in support of the above efforts.

NDIC has been a major contributor to our nation's counternarcotics effort and the U.S. Department of Justice (DOJ) Strategic Plan. A summary of NDIC mission accomplishments during fiscal year (FY) 2008 is now available.
 

Department of Justice Accomplishments 2001-2009

The Accomplishments of the U.S. Department of Justice 2001-2009 (PDF 1.83 MB) lays out the record of accomplishments and results over the past 8 years.
 

SENTRY
SENTRY shield linked to SENTRY web site.SENTRY is an Internet-based system designed to collect and disseminate synthetic drug-related data in order to identify new trends at an early stage, evaluate their likely importance, and track their development.

SENTRY focuses on synthetic drugs that are primarily produced via a chemical process, such as LSD (lysergic acid diethylamide), MDMA (3,4-methylenedioxymethamphetamine, also known as ecstasy), and methamphetamine. To be truly effective as an early warning system, however, the system also monitors prescription drugs, over-the-counter medications, botanical substances and extracts, and chemicals and products involved in the manufacturing of synthetic drugs.

Enter the Sentry Web Site

  


End of page.